Ally Bridge Group as of June 30, 2026
Portfolio Holdings for Ally Bridge Group
Ally Bridge Group holds 25 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Definium Therapeutics Com Shs Call Option (DFTX) | 16.6 | $19M | 400k | 47.04 | |
| Abivax Sa Sponsored Ads Call Option (ABVX) | 14.7 | $17M | 125k | 133.26 | |
| Minerva Neurosciences Com New (NERV) | 10.7 | $12M | 2.2M | 5.55 | |
| Promis Neurosciences Com Shs (PMN) | 7.2 | $8.2M | 620k | 13.16 | |
| First Tracks Biotherapeutics Ord Shs (TRAX) | 5.1 | $5.7M | 284k | 20.12 | |
| Axsome Therapeutics (AXSM) | 3.6 | $4.0M | 17k | 244.77 | |
| Assembly Biosciences Com New (ASMB) | 3.4 | $3.8M | 140k | 27.48 | |
| Aadi Bioscience (WHWK) | 3.3 | $3.7M | 818k | 4.58 | |
| Edgewise Therapeutics (EWTX) | 3.0 | $3.4M | 83k | 40.63 | |
| Eliem Therapeutics (CLYM) | 2.9 | $3.2M | 249k | 13.04 | |
| Kura Oncology (KURA) | 2.8 | $3.2M | 290k | 10.97 | |
| Cytomx Therapeutics (CTMX) | 2.6 | $2.9M | 775k | 3.75 | |
| Avalo Therapeutics Sponsored Ads (AVTX) | 2.5 | $2.8M | 150k | 18.48 | |
| Palisade Bio (PALI) | 2.3 | $2.6M | 1.2M | 2.09 | |
| Solid Biosciences (SLDB) | 2.3 | $2.6M | 256k | 9.99 | |
| An2 Therapeutics (ANTX) | 2.3 | $2.5M | 526k | 4.84 | |
| Urogen Pharma (URGN) | 2.3 | $2.5M | 69k | 36.80 | |
| Perspective Therapeutics Com New (CATX) | 2.2 | $2.5M | 744k | 3.41 | |
| Ideaya Biosciences (IDYA) | 2.2 | $2.5M | 68k | 37.27 | |
| Inventiva Sa Ads (IVA) | 2.1 | $2.4M | 635k | 3.78 | |
| Alumis (ALMS) | 1.9 | $2.2M | 77k | 28.14 | |
| Ovid Therapeutics (OVID) | 1.5 | $1.7M | 625k | 2.69 | |
| Eupraxia Pharmaceuticals (EPRX) | 1.5 | $1.7M | 252k | 6.61 | |
| Ibio Com New (IBIO) | 0.6 | $683k | 390k | 1.75 | |
| Traws Pharma (TRAW) | 0.6 | $663k | 786k | 0.84 |
